MDL | MFCD00051771 |
---|---|
Molecular Weight | 388.48 |
Molecular Formula | C16H17KN2O5S |
SMILES | O=C(O[K])[C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(COC3=CC=CC=C3)=O)N1C2=O |
Penicillin V Potassium (Phenoxymethylpenicillin potassium salt) is an orally active antibiotic . Penicillin V Potassium inhibits the growth of Streptococci , C. difficile and S. aureus . Penicillin V Potassium can be used for the research of otitis, sinusitis, pharyngitis and tonsillitis [1] [2] [3] [4] .
Penicillin V (0.002-8.0 mg/L) inhibits the growth of
Streptococci
, with the minimum inhibitory concentrations (MICs) of 0.004-0.008 mg/L
[2]
.
Penicillin V (0.002-8.0 mg/L) inhibits the growth of
C. difficile
, with a MIC
90
of 8 mg/L
[3]
.
Penicillin V (0.004-0.063 mg/L; 18 h) inhibits the growth of
Staphylococcus aureus
, with a MIC of 0.016 mg/L
[4]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Penicillin V (0.063-0.25 mg/kg; a single s.c.) inhibits the outgrowth of
S. aureus
in mice thigh muscle
[4]
.
Penicillin V (100 mg/kg; p.o. once daily for 5 d) avoids the fulminant infection of acute purulent otitis media (AOM) in rats
[5]
.
Penicillin V (2 mg/kg; a single s.c.) exhibits the plasma half-life (61 min) and mean AUC (0.47 mg/L•h)
[4]
[4]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Specific pathogen free (SPF) male Swiss mice (20-25 g) are inoculated S. aureus [4] |
Dosage: | 0.063, 0.13, 0.25 mg/kg |
Administration: | A single s.c. |
Result: | Decreased the number of CFU (1.34×10 7 counts/mL) compared to controls (3.5×10 7 counts/mL) at the dose of 0.25 mg/kg. |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT01499875 | University of Aarhus|Aarhus University Hospital Skejby|Department of Microbiological Surveillance and Research, SSI. |
Phenoxymethylpenicillin
|
January 2012 | Phase 1 |
NCT02922686 | Royal College of Surgeons, Ireland|Health Research Board, Ireland |
Cellulitis|Wound Infection|Abscess
|
December 2016 | Phase 4 |
NCT02185209 | Margareta Hultin|Karolinska Institutet |
Periodontal Diseases|Periimplantitis
|
March 2015 | Phase 4 |
NCT03208361 | Jordi Gol i Gurina Foundation |
Community-acquired Pneumonia (CAP)
|
November 5, 2013 | Phase 3 |
NCT01368341 | Morten Lindbaek|Norwegian Institute of Public Health|Sorlandet Hospital HF|Norwegian University of Life Sciences|University of Oslo |
Erythema Migrans|Erythema Chronicum Migrans|Borreliosis|Lyme Disease|Early Lyme Disease
|
June 2011 | Phase 4 |
NCT02188472 | Henrik Enghusen Poulsen|Klinisk Biokemisk Afdeling|Klinisk farmakologisk Afdeling|Sektion for Biomedicin Institut for Veterinær Patobiologi|Rigshospitalet, Denmark |
Oxidative Stress
|
November 2010 | Phase 1 |
NCT04084106 | Uppsala University |
Infectious Disease
|
September 10, 2019 | Phase 4 |
NCT00823433 | William Beaumont Hospitals |
Group B Streptococcus
|
January 2009 | Early Phase 1 |
NCT04083417 | Katarina Hedin|Umeå University|Linkoeping University|Lund University|Region Jönköping County |
Sore Throat|Tonsillitis
|
September 9, 2019 | Phase 4 |
NCT03326661 | Odense University Hospital |
Peritonsillar Abscess
|
November 10, 2017 | Not Applicable |
NCT02712307 | Ass. Prof. Katarina Hedin|Public Health Agency of Sweden |
Tonsillitis
|
September 2015 | Phase 4 |
Solid
strains of Penicillium chrysogenum
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : 12 mg/mL ( 30.89 mM ; Need ultrasonic)
H 2 O : 6 mg/mL ( 15.44 mM ; Need ultrasonic and warming)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.5741 mL | 12.8707 mL | 25.7414 mL |
5 mM | 0.5148 mL | 2.5741 mL | 5.1483 mL |
10 mM | 0.2574 mL | 1.2871 mL | 2.5741 mL |
Add each solvent one by one: PBS
Solubility: 100 mg/mL (257.41 mM); Clear solution; Need ultrasonic
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 1.2 mg/mL (3.09 mM); Clear solution
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 1.2 mg/mL (3.09 mM); Clear solution